After decades of progress, there is a renewed need to improve the quality of cardiovascular care due to slipping cardiovascular health outcomes. 1-3 Utilization management strategies such as prior authorization undertaken by payers were intended to facilitate the safe and guideline-adherent provision of new and potentially costly cardiovascular therapies, but patients, clinicians, and payers ....